Consistent with dataset GSE114868, we observed notable reductions in PILRA, LILRA2, MYO1F, and NCF1 expression, alongside significant elevations in HPGDS and MPO expression in AML cell lines compared to normal cells (Figures 9A–D). The gene discussed is LILRA2; the disease is acute myeloid leukemia.